Back to results
US 2019/0167684 A1Published application
Compositions and methods for treating hcv
AssigneeAbbVie Inc.
InventorsChristine A. Collins, Daniel E. Cohen, Gennadiy Koev, Preethi Krishnan, Tami J. Pilot-Matias
Life of this patent
Estimating the term…
Abstract
This disclosure is directed to pharmaceutical compositions that comprise two or more therapeutic agents that, inter alia, are useful for inhibiting hepatitis C virus (HCV) and methods for inhibiting HCV by co-administering two or more anti-HCV therapeutic agents.
Claims20
A combination or pharmaceutical composition comprising an amount of therapeutic agent A and an amount of therapeutic agent B, wherein therapeutic agent A is compound A or a salt thereof:
- and wherein therapeutic agent B is compound B or a salt thereof:
A pharmaceutical composition comprising an amount of therapeutic agent A and an amount of therapeutic agent B,
- wherein therapeutic agent A is compound A or a salt thereof:
- wherein therapeutic agent B is compound B or a salt thereof:
- and
- wherein the ratio of therapeutic agent A to therapeutic agent B is about 1:20 to about 1:2000.
1 more element
Dependencies are inferred from the claim text.